Synosia Therapeutics Begins Phase IIa with Potential Parkinson's ... - PharmaLive.com (press release) by Alzheimers treatment

Sat, 07 Jun 2008 01:36:31 -0400

Synosia Therapeutics Begins Phase IIa with Potential Parkinson's ... - PharmaLive.com (press release)

by Alzheimers treatment @ Sat, 07 Jun 2008 01:36:31 -0400

Synosia Therapeutics Begins Phase IIa with Potential Parkinson's ...
PharmaLive.com ( release), PA -17 hours ago
It is the second most common neurodegenerative disorder, after Alzheimer's disease and affects about one per cent of people aged 65-69 years, ...